Hunan Norchem Pharmaceutical Co.,Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hunan Norchem Pharmaceutical Co.,Ltd. - overview
Established
2013
Location
Changde, Hunan, China
Primary Industry
Biotechnology
About
Based in Changde, China, and founded in 2013, Hunan Norchem Pharmaceutical Co. ,Ltd. operates as a pharmaceutical research and development manufacturer, focusing on steroid drug intermediates and APIs. The company also established more than 10 branch subsidiaries in Hunan, Beijing, Guangdong, and other places.
It has also established two intermediate factories, a sex hormone API factory, and a formulation factory. Norchem has applied for 27 invention patents, 17 of which have been granted. In December 2023, the company closed pre-IPO funding. Norchem is dedicated to the production of various pharmaceutical APIs and intermediates using biological fermentation and chemical synthesis with phytosterols as the starting material.
The products of the company can be categorized into five categories which are betamethasone series, dexamethasone series, hydrocortisone series, prednisolone series, and progestin intermediates. Products within include betamethasone epoxide hydrolysate, dexamethasone epoxide hydrolysate acetate, hydrocortisone intermediate ester, prednisolone acetate, and acid decarboxylate.
Current Investors
OrbiMed Advisors, Cathay Capital, China International Capital Corporation
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.norchem-pharma.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.